CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 121 enrolled
Drug / intervention
Epaderm Creamdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03738163
NCT03738163N/ACompleted
CompareCT.gov

A Prospective Post Market Clinical Follow-up Investigation With Epaderm® Cream to Confirm Performance and Safety Parameters

Molnlycke Health Care AB·interventional·Posted Nov 13, 2018·Updated Jun 23, 2021

In Brief

A clinical study evaluating Epaderm Cream for Eczema and 2 related conditions. Completed, enrolled 121 participants across 2 sites.

Detailed Summary

This investigation is designed as a prospective, non-randomised, single arm clinical investigation. Data is collected from approximately 120 evaluable subjects, divided into three groups of approximately 40 subjects; infants (0-36 months old), children (3-18 years old) and adults (\>18 years old), with the following indications: eczema, psoriasis and other dry skin conditions. Each subject will be followed during 4 weeks treatment, with a visit at baseline (visit 1), at 2 weeks (visit 2) and at 4 weeks (visit 3) treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEczema, Psoriasis, Dry Skin; Eczema
CountriesUnited Kingdom
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedNov 13, 2018
Enrollment StartApr 1, 2019
Primary CompletionOct 25, 2019
Study CompletionJun 17, 2020
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 7.6 years ago

Interventions

Epaderm Creamdevice

The treatment with the investigational device will be according to the prescription by the investigator together with the instruction stated on the investigational device.